Skip to main content

Table 3 Basic demographics and hyaluronic acidlevels in ischemic stroke patients with different subtypes based on the TOAST classification

From: Association between plasma levels of hyaluronic acid and functional outcome in acute stroke patients

 

Large-artery atherosclerosis (n = 47)

Small vessel occlusion (n = 44)

Cardio-embolism (n = 30)

Others (n = 42)

Age (years)

64.0 ± 12.8

65.0 ± 13.7

68.8 ± 11.9

64.9 ± 15.2

Male

37 (78.7)

31 (74.5)

18 (60.0)

25 (59.5)

Body mass index (kg/m2)

25.4 ± 3.2

26.4 ± 3.9

24.9 ± 3.0

25.9 ± 4.2

Diabetes mellitus

23 (48.9)

16 (36.4)

11 (36.7)

17 (40.5)

Hypertension

33(70.2)

29 (65.9)

23 (76.7)

34 (81.0)

Hyperlipidemia

16 (34.0)

16 (36.4)

5 (16.7)

16 (38.1)

Atril fibrillation

0 (0)

0 (0)

26 (74.1)**

16 (38.1)**

History of stroke

14(30.0)

7(15.9)

9 (30.0)

6 (14.3)

NIHSS

10.9 ± 8.4**

4.7 ± 4.6

14.9 ± 6.2**

7.6 ± 7.6

mRS ≤2

17 (36.2)

29 (65.9)**

9 (30.0)

27 (64.3)**

HA <48 hours (ng/ml)

194.7 ± 186.4

213.4 ± 258.3

258.6 ± 191.5

192.2 ± 178.3

HA (ng/ml) 48 to 72 hours (ng/ml)

218.8 ± 270.41

189.5 ± 260.8

508.4 ± 879.8*

316.2 ± 644.7

  1. Values are shown as number (percentage) or mean ± standard deviation. HA, hyaluronic acid; mRS, modified Rankin scale; NIHSS, National Institute of Health Stroke Scale; Others, specific etiology, and undetermined etiology in TOAST classification; TOAST, Trial of ORG 10172 in Acute Stroke Treatment.
  2. The values of all pairs of columns were compared to each other.*P < 0.05, ** P < 0.01.